Gene · 6369
Papers2,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Eosinophilic Chronic Rhinosinusitis and Pathogenic Role of Protease. | Int J Mol Sci | 2023 | 38139201 | PubTator, text mining | PubMed |
| Inflammation in Prostate Cancer: Exploring the Promising Role of Phenolic Compounds as an Innovative Therapeutic Approach. | Biomedicines | 2023 | 38137361 | PubTator, text mining | PubMed |
| Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC. | Oncoimmunology | 2023 | 38126028 | PubTator, text mining | PubMed |
| DJ-1: A Potential Biomarker Related to Prognosis, Chemoresistance, and Expression of Microenvironmental Chemokine in HR-Positive Breast Cancer. | J Immunol Res | 2023 | 38125697 | PubTator, text mining | PubMed |
| Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia. | Pain Rep | 2023 | 38125050 | PubTator, text mining | PubMed |
| Editorial: Immunology of cachexia. | Front Immunol | 2023 | 38116001 | PubTator, text mining | PubMed |
| Resurgence of syphilis: focusing on emerging clinical strategies and preclinical models. | J Transl Med | 2023 | 38105236 | PubTator, text mining | PubMed |
| Cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet. | Front Immunol | 2023 | 38090567 | PubTator, text mining | PubMed |
| Amyloid β,α-Synuclein and Amyloid β-α-Synuclein Combination Exert Significant but Different Alterations in Inflammatory Response Profile in Differentiated Human SH-SY5Y Cells. | ACS Omega | 2023 | 38075821 | PubTator, text mining | PubMed |
| A two-sample Mendelian randomization analysis: causal association between chemokines and pan-carcinoma. | Front Genet | 2023 | 38075694 | PubTator, text mining | PubMed |
| In-depth exploration of the shared genetic signature and molecular mechanisms between end-stage renal disease and osteoporosis. | Front Genet | 2023 | 38075679 | PubTator, text mining | PubMed |
| Differential molecular profiles and associated functionalities characterize connective tissue grafts obtained at different locations and depths in the human palate. | Int J Oral Sci | 2023 | 38072943 | PubTator, text mining | PubMed |
| M2-Macrophage-Induced Chronic Inflammation Promotes Reversible Mesenchymal Stromal Cell Senescence and Reduces Their Anti-Fibrotic Properties. | Int J Mol Sci | 2023 | 38069411 | PubTator, text mining | PubMed |
| Nanocarrier-Mediated Immunogenic Cell Death for Melanoma Treatment. | Int J Nanomedicine | 2023 | 38059000 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: an effective player of the tumor microenvironment. | Front Immunol | 2023 | 38035101 | PubTator, text mining | PubMed |
| Dermis resident macrophages orchestrate localized ILC2 eosinophil circuitries to promote non-healing cutaneous leishmaniasis. | Nat Commun | 2023 | 38030609 | PubTator, text mining | PubMed |
| Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5). | Front Pharmacol | 2023 | 38026988 | PubTator, text mining | PubMed |
| Immune mediators as predictive biomarkers for anti-PD-1 antibody therapy in urothelial carcinoma. | Front Pharmacol | 2023 | 38026978 | PubTator, text mining | PubMed |
| Derived myeloid lineage induced pluripotent stem as a platform to study human C-C chemokine receptor type 5Δ32 homozygotes. | iScience | 2023 | 38026202 | PubTator, text mining | PubMed |
| A unique role for IL-13 in inducing esophageal eosinophilia through MID-1 and STAT6. | Front Allergy | 2023 | 38026128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6369/papers?page=8